40
nanotimes
Companies Facts
in the past. This means richer, more viscerally vibrant reds and a deeper palette of greens – the colour the human eye sees more intensely than any other colour. Designed to be process-ready, display makers can easily integrate QDEF™ into current manufactu- ring operations without retooling an existing line, as is the case with other technologies.
QDEF™ is engineered using Nanosys’ patented quantum dot materials dispersed in a polymer matrix and suspended within an optical film. The advanced material creates an improved quality white light with an unprecedented range of hues when excited by an energy-efficient blue LED. This results in better colour and less power consumption than when using white LEDs. Last year, Nanosys commercialized its quantum dot technology with the QuantumRail™, a process-ready component for smaller format LCDs that improves colour gamut and power efficiency. The company plans to expand its manufacturing capacity as it continues to commercialize its LCD and energy storage technologies.
http://www.nanosysinc.com
http://www.nanostart.de N
ano Terra, Inc., a leading surface engineering and nanotechnology co-development company,
is acquiring Surface Logix, Inc. The Company is a drug development company which uses its expertise in biophysical chemistry to create new small molecu- le drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compa- red with current class leaders.
By using its proprietary chemistry platform – the Pharmacomer™ Technology Platform – Surface Logix
11-04 :: April/May 2011
creates New Chemical Entities (NCEs) that respond dynamically to the various physiological microenvi- ronments in the human body. By enhancing molecu- lar functionality, Surface Logix is able to solve PK and PD problems not addressable with traditional medici- nal chemistry practices.
“Surface Logix is an excellent fit for Nano Terra since our business was also built on intellectual property from the Whitesides lab,” said Myer Berlow, CEO of Nano Terra. “We think we can achieve signifi- cant synergies through our proven co-development model. This acquisition opens the door to the use of Nano Terra’s technology in a variety of healthcare products.”
Nano Terra is a privately-held research and develop- ment company which has field-exclusive licenses to more than 50 patents on work done by co-founder George Whitesides at the renowned Whitesides Lab at Harvard University, where he is the Woodford L. and Ann A. Flowers University Professor. Whitesides was the winner of the prestigious B. Franklin Medal in Chemistry in 2009. (See on page 32 Kadmon)
http://www.surfacelogix.com
http://www.nanoterra.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93